Navigation Links
Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
Date:12/14/2008

ology owned by Pacira. Two other DepoFoam-based products -- DepoDur(R) and DepoCyt/DepoCyte(R) -- are marketed by partners in several global territories. The DepoFoam technology also forms the basis of multiple development projects providing Pacira an opportunity to expand its pipeline. Pacira owns two cGMP production facilities which produce the two approved products, EXPAREL clinical development and all pipeline materials.

Additional information about Pacira is available at www.pacira.com.

This news release and the anticipated presentation contain forward-looking statements that involve risks and uncertainties, including statements relating to initiation and progress of the Company's clinical trial programs and the preliminary results from the clinical trials. Actual results could differ materially from those projected and the Company cautions readers not to place undue reliance on the forward-looking statements contained in the release and anticipated presentation.

Editor's Notes:

-- "A single administration of DepoBupivacaine(TM) intraoperative results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repair" by Richard M. Langford, FRCA; G.M Chappell, FRACS; Jeff A. Karrasch, FRACP, poster presented December 14, 2008 at the PostGraduate Assembly in Anesthesiology (PGA) of the New York State Society of Anesthesiologists, is available at www.pacira.com

-- Pacira Pharmaceuticals executives are available for interviews upon request.

CONTACT: Taunia Markvicka, 973-254-3565.


'/>"/>
SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
2. Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine
3. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
4. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
5. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
6. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
7. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
8. Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
9. Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 According to a ... Software Market by Functionality (Adverse Event Reporting, Fully Integrated ... (Pharma & Biotech Companies, CROs, BPOs) - Global ... and Drug Safety Software Market is poised to ... and is expected to reach a value of ...
(Date:3/26/2015)... , March 26, 2015  Becton, Dickinson and ... it will commence offers to exchange all validly tendered ... CareFusion Corporation, a wholly owned subsidiary of BD, for ... the table below. A Registration Statement on Form S-4 ... New Notes was filed with the Securities and Exchange ...
(Date:3/26/2015)... MOUNT PROSPECT, Illinois , 26. März ... of Pharmacy® (NABP®) wird vom 1. April 2015 ... .pharmacy von allen abgebenden Apotheken annehmen. Seit ... 2014 hat der Verband über 275 .pharmacy-Domainnamen ... bzw. während dieser Zeiten beantragt wurden. Die ...
Breaking Medicine Technology:Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
(Date:3/26/2015)... In the key developed markets, the hypertension ... is set to decrease through 2020 at a negative CAGR ... expected up to 2017 at a 2.6% CAGR and a ... to the surging penetration of fixed-dose combination drugs like Azor, ... Benicar HCT, and Tekamlo), a hike in the prevalence population ...
(Date:3/26/2015)... Leading nutritional supplement provider Metabolic ... http://www.metabolicnutrition.com . The ultramodern, clean and ... user-friendly experience for consumers seeking information about the ... enhanced Metabolic Nutrition website includes: , ... line of products, conveniently broken down by user ...
(Date:3/26/2015)... 26, 2015 Zane Benefits, the leader ... a new eBook, “The Comprehensive Guide To Interviewing For ... is the most important aspect of the hiring process. ... hiring the right way, possibly resulting in thousands of ... arduous undertaking, yet it’s essential to the success of ...
(Date:3/26/2015)... LinkToBanking, a Preferred Partner Network for the ... Chairman of the Board and Robert Casares as ... their combined knowledge and experience in regulatory compliance ... Mr. Casares will provide exceptional guidance on how ... , About Tom Fleming, Mr. Fleming, CAMS, has ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 3
... N.H. -- A Dartmouth-led study of young U.S. teens ... or other items featuring an alcohol brand, and those ... stages of drinking from susceptibility, to beginning drinking, to ... issue of Archives of Pediatrics & Adolescent Medicine ...
... Gastric bypass surgery can restore function for obese males, study ... obese a man, the greater his hormonal changes and the ... the up side, the study,s authors found that gastric bypass ... found that obesity is correlated to lower sperm count and ...
... and first for long-term investment and social responsibility in ... (NYSE: DGX ), the world,s leading provider ... named to FORTUNE magazine,s list of the World,s Most ... Care" category of "Pharmacy and Other Services." The 2009 ...
... benefit decision when selecting long-term care insurance. , ... Newark, NJ (PRWEB) ... care insurance are scaring you off, Prudential has a way ... with few options to confuse the decision-making process., , , , ,Although ...
... Fourth Consecutive Year DaVita Ranks as One of the ... DaVita Inc., a leading provider of kidney care services, ... as one of the top health care facilities in ... Health Care Medical Facilities for innovation, Long-Term Investment and ...
... March 3 Cantel Medical Corp. (NYSE: CMN ... results for its second quarter ended January 31, 2009 on ... the call will be Charles M. Diker, Chairman; Andrew A. ... and Roy K. Malkin, President of Minntech Corporation. Minntech is ...
Cached Medicine News:Health News:Owning alcohol-branded merchandise associated with teen drinking behaviors 2Health News:Men's Sex Lives May Suffer as Waistlines Expand 2Health News:Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List 2Health News:Prudential Long-Term Care Product Simplifies Decisions 2Health News:Prudential Long-Term Care Product Simplifies Decisions 3Health News:FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality 2Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2009 2
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
... lineup of high-powered Xenon, Metal Halide ... brightness in a durable, lightweight design. ... quality light guide cables, providing optimal ... durable design., Extraordinarily compact yet offering ...
... A full lineup of high-powered Xenon, ... optimal brightness in a durable, lightweight design. ... light guide cables, providing optimal brightness in ... for use with the VISERA imaging system, ...
... The ALU-2B Halogen Light ... ALU-1B, with the addition of ... intensity display. This light source ... procedures and has the added ...
Medicine Products: